Congo, The Democratic Republic of the
News Category
Congo’s Copper and Cobalt Production Unaffected by Middle East Crisis, Says Official
Despite Middle East unrest disrupting key mining inputs, the Democratic Republic of Congo's copper and cobalt production remains unaffected and export...
NanoViricides Advances NV-387 Toward Phase II Trial for Bundibugyo Ebola in DRC
NanoViricides is progressing its oral gummies formulation of NV-387 toward a Phase II trial for the Bundibugyo ebolavirus outbreak in the DRC, where n...
NanoViricides Ships NV-387 to DRC for Phase II MPox Trial, Expanding Broad-Spectrum Antiviral Potential
NanoViricides has shipped its broad-spectrum antiviral candidate NV-387 to the Democratic Republic of Congo for a Phase II trial against MPox, with im...
NanoViricides Receives DRC Approval to Advance Proposed Phase II Ebola Trial
NanoViricides announced that the Pillar Committee in Charge in the Democratic Republic of Congo has approved its proposal to conduct a Phase II clinic...
Redwood AI Signs LOI for AI-Enabled Pathogen Surveillance Initiative in East Africa
Redwood AI Corp. has signed a non-binding letter of intent to develop an AI-driven pathogen tracking and outbreak intelligence initiative in Rwanda an...
Trident Digital Tech Launches TDTHAI Enterprise AI Platform for Asia-Pacific Markets
Trident Digital Tech Holdings Ltd. announced the launch of TDTHAI, an AI platform aimed at enterprise deployment, workflow automation, and digital tra...
US CDC Expands Ebola Travel Ban to Include Green Card Holders
The CDC broadens its travel ban to include legal permanent residents from Uganda, South Sudan, and the DRC, raising concerns among healthcare stakehol...
NanoViricides Highlights NV-387 as Potential Candidate for Bundibugyo Ebola Outbreak
NanoViricides flags its broad-spectrum antiviral NV-387 as a potential treatment for the Bundibugyo Ebola strain, which lacks approved vaccines or the...
NanoViricides Highlights Broad-Spectrum Antiviral Candidate NV-387 Amid Ebola Outbreak
NanoViricides underscores the potential of its oral drug candidate NV-387 as a pandemic preparedness tool for Ebola and related filoviruses, leveragin...
NanoViricides Advances NV-387 Toward Phase II Trials for MPox and Other Viral Diseases
NanoViricides reported progress in developing its broad-spectrum antiviral candidate NV-387, including regulatory approval for a Phase II MPox trial i...
Iran Conflict Disrupts Chemical Supply for DRC’s Cobalt and Copper Miners
Ongoing conflict in Iran is straining the supply of critical processing chemicals for cobalt and copper miners in the Democratic Republic of Congo, fo...
NanoViricides to Initiate Phase II MPox Trial in DRC
NanoViricides announced a Phase II clinical trial of NV-387 for MPox in the Democratic Republic of Congo, evaluating safety and efficacy against Clade...
US Firm Virtus Minerals to Acquire DRC Lithium and Cobalt Producer Chemaf
Virtus Minerals, a US-based critical minerals company, will acquire Chemaf, a DRC miner of lithium and cobalt, signaling increased Western investment ...
Easy Environmental Solutions Reports Strong Q1 2026 Growth Amid Global Nitrogen Shortage
Easy Environmental Solutions (EZES) leverages its Terreplenish organic microbial solution to address rising nitrogen fertilizer shortages and prices, ...
NanoViricides to Present at NIBA Conference as NV-387 Oral Gummies Drug Supply Completed
NanoViricides announced the completion of NV-387 Oral Gummies manufacturing and its upcoming presentation at the NIBA Investment Conference, highlight...
DR Congo Resumes Cobalt Exports After 10-Month Ban, Highlighting Supply Chain Vulnerabilities
The Democratic Republic of Congo has lifted its 10-month ban on cobalt exports, underscoring the risks of concentrated supply in critical minerals mar...
Micropolis AI Robotics Expands into African Markets with $9.3M Development and Distribution Deal
Micropolis AI Robotics has signed a $9.3 million agreement with AfricAI to develop three customized unmanned ground vehicles for African markets and s...
NanoViricides President Discusses Broad-Spectrum Antiviral Platform and NV-387 Progress in Mission Matters Podcast Interview
NanoViricides (NYSE American: NNVC) President Dr. Anil Diwan highlighted the company's nanoviricide platform and lead candidate NV-387, which has show...